Time-to-event endpoints. TTR (A), DOR (B), PFS overall (C), and PFS by higher or lower dosing regimen (D). TTR and PFS are measured from the start of therapy, whereas DOR is measured from the start of response. TTR and DOR comprise responding patients only; PFS is evaluated in all patients. A tick on the curve denotes a censored time point.